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Comparison of 1.5T and 3T 
1H MR
Spectroscopy for Human Brain Tumors
Objective: We wanted to estimate the practical improvements of 3T proton MR
spectroscopy (
1H MRS) as compared with 1.5T 
1H MRS for the evaluation of
human brain tumors. 
Materials and Methods: Single voxel 
1H MRS was performed at both 1.5T and
3T in 13 patients suffering with brain tumors. Using the same data acquisition
parameters at both field strengths, the 
1H MRS spectra were obtained with a short
echo time (TE) (35 msec) and an intermediate TE (144 msec) with the voxel size
ranging from 2.0 cm
3 to 8.7 cm
3. The signal to noise ratios (SNRs) of the metabo-
lites (myoinositol [MI], choline compounds [Cho], creatine /phosphocreatine [Cr],
N-acetyl-aspartate [NAA], lipid and lactate [LL]) and the metabolite ratios of
MI/Cr, Cho/Cr, Cho/NAA and LL/Cr were compared at both TEs between the two
field strengths in each brain tumor. The degrees of spectral resolution between
the Cho and Cr peaks were qualitatively compared between the two field
strengths in each brain tumor. 
Results: The SNRs of the metabolites at 3T demonstrated 49 73% increase
at a short TE (p < 0.01) and only 2 12% increase at an intermediate TE (p >
0.05) compared with those of 1.5T. The SNR of inverted lactate at an intermedi-
ate TE decreased down to 49% with poorer inversion at 3T (p < 0.05). There was
no significant difference in the metabolite ratios between the two field strengths.
The degrees of the spectral resolution at 3T were slightly superior to those of
1.5T at a short TE. 
Conclusion: As compared with 1.5T, 3T 
1H MRS demonstrated 49 73% SNR
increase in the cerebral metabolites and slightly superior spectral resolution only
at a short TE, but little at an intermediate TE, in the brain tumors. There was no
significant difference in the metabolite ratios between the two field strengths.
n vivo proton magnetic resonance spectroscopy (
1H MRS) provides
completely different information on the basic metabolic processes such as
cell proliferation or degradation, energy metabolism, neuronal integrity
and necrotic transformation of the brain tumor tissues, and this stands in contrast to
the methods that provide structural data, such as MRI, CT and angiography (1 3).
The spectroscopic studies on brain tumors have been attempted to characterize the
different histologic types and predict the degree of malignancy of the gliomas.
Noninvasive grading is especially important for the tumors in the eloquent areas or for
the deeply located tumors. However, despite the expectations of noninvasively
characterizing tumor by performing clinical 
1H MRS, some of previous studies have
yielded rather disappointing results that there was no reliable indicator for discriminat-
ing among the tumor types or among the malignant and benign neoplasms (2, 4, 5).
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IThis may be partially due to the limited spatial and spectral
resolution obtained at the standard magnetic field of 1.5T
(3). 
With the integration of 3T MRI into clinical practice,
there is growing interest in the practical improvement of
1H MRS at a 3T field strength with respect to the
established magnetic field strength of 1.5T because both
the spectral resolution and the spatial resolution depend, in
a linear fashion, on the magnetic field (6 9). 
Although single-voxel 
1H MRS of the human brain has
been performed at many field strengths from 0.5T to 7T,
there have been few direct comparisons between the
current standardized 1.5T and 3T in the same human brain
or in phantoms with using the same methodology (6, 7, 9).
According to those reports, the expected gains in the signal
to noise ratio (SNR) and the spectral resolution were
partially achieved in the normal human brain due to many
factors at a higher field strength (6, 7). We tried to
evaluate practical improvements of 
1H MRS at 3T as
compared with 1.5T in patients suffering with brain tumor
in terms of the SNR and the spectral resolution. 
MATERIALS AND METHODS
Patients
Our study included 13 patients (6 men and 7 women,
age range: 18 69 years, mean age: 45.9) with a previously
untreated brain tumor. The postoperative diagnosis of
brain tumors included three glioblastomas, two anaplastic
astrocytomas, two anaplastic oligodendrogliomas, one
oligodendroglioma, one metastasis, one lymphoma, one
pineocytoma, one central neurocytoma and one
meningioma. All the patients provided us with an informed
consent for participation in the study, and this study was
approved by our institutional review board.
1H MRS Methods
All the 
1H MRS studies were performed by using the
automated single-voxel MRS package Proton Brain
Examination/Single Voxel with both 1.5T and 3T scanning
units (GE Medical Systems, Milwaukee, WI) that were
equipped with circularly polarized head coils. In each
patient, we obtained the spectra from voxels of the same
size that contained the same area by using the point-
resolved spectroscopy (PRESS) pulse sequences with the
same repetition time (TR) and echo time (TE); there was a
two week interval between the 1.5T and 3T examinations.
The parameters of the short TE (2,000/35) (TR/TE) and
intermediate TE (1,500/144) sequences were applied to the
examinations with both fields.
MR imaging with the T2-weighted fast spin echo
sequences (4,000 5,000/104 121, 24-cm field of view,
256 224 matrix and 5-mm sections) in the axial or
coronal planes preceded 
1H MRS in order to define the
volume of interest (VOI). The VOIs varied from 2.0 cm
3 to
8.7 cm
3 depending on the tumor size. The size and location
of the voxel were carefully adjusted to include as much of
either the nonenhancing or homogeneously enhancing
solid portion as possible, as was determined from the
previously obtained MR images. We intended to avoid
inclusion of the voxels of the obvious necrosis, cyst,
hemorrhage, edema, calcification and normal appearing
brain. All the 
1H MRS examinations were performed
without administration of contrast agent. 
All spectra were processed using Mrdx (CAD Impact,
Inc., Seoul, Korea) based on IDL (Research Systems, Inc.,
Boulder, CO). Typical full widths at half maximum of 3 to
6 Hz were achieved on most examinations. The water
signal was suppressed by a frequency-selective saturation
pulse at the water resonance. A sweep width of 1,000 Hz
was used with a data size of 1,024 points. Only the second
half of the echo was acquired. Following the zero-filling of
8,192 points in all the free induction-decay data, an
exponential line broadening (center: 0 milliseconds, half
time: 150 milliseconds) was done before Fourier transfor-
mation. Zero-order phase correction was applied to all
spectra. 
Evaluation and Statistical Analysis
For the semiquantitative evaluation, we estimated the
levels of myoinositol (MI), choline compounds (Cho),
creatine/phosphocreatine (Cr), and N-acetyl-aspartate
(NAA) as the heights of the peaks at 3.6, 3.2, 3.0, and 2.0
ppm in respect to both TEs of the two field strengths. We
defined and estimated the sum of the peak heights
between 0.9 and 1.3 ppm as lipid and lactate (LL) at the
short TE. We defined and estimated the sum of the upright
lipid peak at around 0.9 1.3 ppm and also the absolute
value of the inverted lactate peak at 1.3 ppm as the LL at
the intermediate TE. 
In order to compare the degree of inversion of lactate at
the intermediate TE between the two fields, we estimated
the absolute value of the inverted lactate peak at 1.3 ppm
on both fields in seven patients who showed lactate
inversion at the intermediate TE on 1.5T. The SNRs of all
the metabolites were estimated by taking the ratios of the
metabolite peak height to the standard deviation of the
noise ( noise), which was estimated from the signal-free 0
to  5 ppm region.
The metabolite ratios of MI/Cr, Cho/Cr, Cho/NAA and
LL/Cr were also calculated. For the qualitative evaluation
of spectral resolution, the degree of baseline Cho-Cr
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of each metabolite’s SNR and the metabolite ratios at both
fields were described as means standard deviations (SD).
SPSS (version 11.0; SPSS Inc, Chicago, lL) was used for
statistical analysis.
Nonparametric tests were applied throughout, as the
number of cases was not sufficiently high to assume a
normal distribution. The Wilcoxson signed rank tests for
matched pairs were performed to compare the SNRs of the
metabolites and the metabolite ratios at both TEs between
the 1.5T and 3T. P values less than 0.05 were considered
to indicate a statistically significant difference.
RESULTS
The 3T/1.5T SNR ratios of the metabolites at both TEs
are given in Figure 1 and Table 1. At a short TE, the SNRs
of the metabolites at a 3T strength increased, i.e., 49.4%
for NAA and 72.6% for LL (p < 0.01) and the SNRs were
better in all the patients as compared with the SNRs at
1.5T (Fig. 2). However, at an intermediate TE, the SNRs of
the metabolites at 3T increased only 2.4% and 11.6% for
NAA, Cr, respectively (p > 0.05). There were rather worse
SNRs at the intermediate TE of 3T in six patients whose
tumors were located near the calvarium and/or they had
portions of hemorrhage (Fig. 3). 
In seven patients who showed lactate inversion at an
intermediate TE on 1.5T, the SNRs of the inverted lactate
decreased down to 49.2 18.5% at 3T. Out of the seven
patients, the inverted lactate peaks were indiscernible in
four patients and they were smaller in three patients at 3T
(Figs. 2 and 3).
The mean metabolite ratios at both TE sequences at 3T
and 1.5T are given in the Table 2. There was no statistical
difference in any of the metabolite ratios between both
fields. 
For the qualitative assessment of spectral resolution at
3T, seven out of 13 patients showed better Cho-Cr separa-
tion at a short TE and three patients with brain tumor
showed at an intermediate TE as compared with 1.5T (Fig.
2). 
DISCUSSION
In the present study, the theoretical gain of twofolds for
the SNR of each metabolite was not fully realized with 3T.
A partial gain (49.4 72.6%) was obtained at a short TE
with 3T as compared with 1.5T. At an intermediate TE,
there was little significant SNR gain with 3T. The spectral
resolution was also partly improved, and particularly at a
short TE with 3T. 
Barker et al. (7) reported that the spectra of the normal
human brains at 3T demonstrated a 20% improvement of
the SNR compared to 1.5T at a short TE (20 msec);
Kim et al.
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Fig. 1. Standard error graph of the 3T/1.5T signal to noise ratios
of each metabolite in the patients with brain tumor (n = 13).
The small square is the mean, and the upper and lower
transverse lines show the 95% values of the data. The 3T/1.5T
signal to noise ratios of all the metabolites are significantly
increased at a short echo time: however, they were not at an
intermediate echo time.
Table 2. Mean Metabolite Ratios at 1.5T and 3T in 13 Brain
Tumor Patients 
Mean Short TE Intermediate TE
Metabolite 
Ratio 1.5T 3T 1.5T 3T
MI/Cr 1.16 0.40 1.04 0.37 0.68 0.63 0.56 0.34
Cho/Cr 2.36 1.14 2.25 0.88 3.43 1.99 3.27 1.78
Cho/NAA 1.99 0.71 2.20 1.13 4.92 4.43 5.05 3.42
LL/Cr 3.48 4.56 3.32 3.55 1.79 1.84 1.79 1.45
Note. There was no significant difference in any metabolite ratio 
between 1.5T and 3T (p > 0.05).
Table 1. 3T/1.5T Signal to Noise Ratios of Each Metabolite in
the Patients with 13 Brain Tumors 
Metabolite 3T/1.5T SNR  3T/1.5T SNR 
at a Short TE (%) at an Intermediate TE (%)
MI 166.6 58.1 107.8 39.1
Cho 155.0 33.4 104.7 28.8
Cr 157.1 33.6 111.6 41.5
NAA 149.4 36.3 102.4 38.6
LL 172.6 31.2 108.1 50.6
Note. SNR = signal to noise ratio; TE = echo time; MI = myoinositol; 
Cho = choline compounds; Cr = creatine/phosphocreatine; 
NAA = N-acetyl-aspartate; LL = lipid and lactatehowever the spectra at a long TE (272 msec) exhibited a
similar SNR at both field strengths with using the
stimulated-echo acquisition mode (STEAM) sequences.
Despite the expected advantages that should be obtained
with using high strength fields, the limited SNR improve-
ments might be explained by many factors. They include
increased magnetic field inhomogeneity, poorer radiofre-
quency coil efficiency, poorer shimming and different
relaxation times (6, 7, 9, 10). Therefore, in order to realize
the theoretical improvements, these factors should be
overcome and adjusted for at a field strength of 3T.
The T1 relaxation times increase at higher fields, leading
to increased signal saturation for a given TR. To maintain
the same level of saturation, the acquisition TR should be
lengthened with increasing the total acquisition times or
decreasing the signal averaging in the same total acquisi-
tion time. As the T2 relaxation times decrease at higher
fields, the TE should be shortened. However the optimal
TR and TE at 3T have not yet been well established. 
Barker et al. (7) explained that the similar SNR at a long
TE on both fields was because the long TE sequence was
more influenced by the decreased T2 relaxation time in the
high field than it being influenced by the short TE
sequence.
The SNR gain seen at a short TE in the present study was
larger than that of Barker’s study. This was presumably
because for PRESS, there was much less signal loss of the
coupled spin signals than for STEAM (11, 12).
Gonen et al. (6) reported that there was a 23 46% SNR
gain at a TE of 135 ms with 3T versus 1.5T in the 3D
chemical shift imaging with using the PRESS sequence in
the normal human brain, and this is in contrast to the
results of the small SNR gain at an intermediate TE in the
present study with brain tumor patients. It is postulated
that the tumor’s own heterogeneity might offset the
expected gain of the SNR as compared with the normal
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Fig. 2. A 40-year-old woman with
anaplastic astrocytoma. 
A. The axial T2-weighted image
reveals a mass of high signal intensity
with a square voxel (7.1 cm
3) at the
left high frontal lobe. 
B. The 
1H MR spectrum obtained at a
short TE on 1.5T shows markedly
increased Cho/Cr, decreased NAA/Cr
and increased lipid and lactate. 
C. The 
1H MR spectrum obtained at
an intermediate TE on 1.5T shows an
inverted lactate peak at 1.3 ppm in
addition to increased Cho/Cr. 
D. The 
1H MR spectrum obtained at a
short TE on 3T shows a better SNR
and better spectral resolution between
Cho and Cr than on 1.5T (B), and it is
otherwise similar to 1.5T (B). 
AB C
E. The 
1H MR spectrum obtained at an intermediate TE on 3T shows an inverted lactate peak at 1.3 ppm that is significantly smaller than
that of 1.5T (C). 
DEhuman brain at the intermediate or long TE sequences.
Tumors are inherently heterogeneous and their spectra
have been described as a combination of viable tumor with
both necrotic and cystic tissue, as well as the infiltration of
the normal brain tissue. The involvement of paramagnetic
material in tumor tissue such as intratumoral microscopic
hemorrhage may also cause a susceptibility effect and so
cause T2 shortening. Blood vessels and cerebrospinal fluid
increase the magnetic susceptibility effect by pulsation as
well (12, 13).
As for the inverted lactate peak at 1.3 ppm of the
intermediate TE spectrum, the SNR on 3T was rather much
smaller than that of 1.5T in the present study. This might
be related to the increased susceptibility and the T2
shortening effect with 3T. 
For lactate inversion, the intermediate TE value used at
1.5T might not be appropriate at 3T. Because there was no
significant difference in the metabolite ratios (MI/Cr,
Cho/Cr, Cho/NAA and LL/Cr) between the two fields, we
may well apply the established methods of 1.5T concern-
ing the metabolite ratios for the evaluation of brain tumors
at 3T.
CONCLUSION
For the 3T 
1H MRS of brain tumors, there were 49 73%
SNR increases of the major cerebral metabolites and also
better spectral resolution (n = 7/13) at a short TE (35
msec): however, little at an intermediate TE (144 msec),
compared with 1.5T. The SNR of inverted lactate at an
intermediate TE decreased to 49% at 3T. There was no
significant difference in the metabolite ratios of MI/Cr,
Kim et al.
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Fig. 3. A 49-year-old man with
anaplastic oligodendroglioma.
A. The axial T2-weighted image
reveals a heterogenous mass with
probable hemorrhagic portion in the
right frontal lobe. A rectangular voxel
(2.3 cm
3) contains the solid tumor
portion, including a small possibly
hemorrhagic area, and it is located
close to the calvarium.
B. The 
1H MR spectrum obtained at a
short TE on 1.5T shows slightly
elevated Cho/Cr and decreased
NAA/Cr with many noisy signals.
C. The 
1H MR spectrum obtained at an
intermediate TE on 1.5T shows
elevated Cho/Cr, decreased NAA/Cr
and an inverted lactate peak (1.3 ppm).
D. The 
1H MR spectrum obtained at a
AB C
short TE on 3T shows slightly elevated Cho/Cr and decreased NAA/Cr with a slightly better SNR and shimming compared with the 1.5T
(B).
E. The 
1H MR spectrum obtained at an intermediate TE on 3T shows much more noise than that of the 1.5T (C) and there is no
discernible inverted lactate peak at 1.3 ppm, and this is presumably due to the high susceptibility effect secondary to probable intratu-
moral hemorrhage and the close proximity to the calvarium.
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Cho/Cr, Cho/NAA and LL/Cr between 1.5T and 3T.
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